Last updated on February 2018

A Study in Subjects With Moderate Atopic Dermatitis


Brief description of study

This is a randomized, double-blind, vehicle-controlled study to evaluate the safety and efficacy of ALX-101 Gel 1.5% and 5% and a matching ALX-101 Gel Vehicle when applied topically twice daily for 42 days to adult and adolescent subjects with moderate atopic dermatitis.

Detailed Study Description

The main objectives of this study are to:

  • Evaluate the safety and tolerability of ALX-101 Gel 1.5% and 5% when applied topically in subjects with moderate atopic dermatitis compared with a matching ALX-101 Gel Vehicle
  • Evaluate the dose-response relationship of ALX-101 Gel 1.5% and 5% when applied topically twice daily in subjects with moderate atopic dermatitis compared with a matching ALX-101 Gel Vehicle.

Clinical Study Identifier: NCT03175354

Contact Investigators or Research Sites near you

Start Over

Patrice Horwath

Ralexar Investigational Site 35
Anniston, AL United States
  Connect »

Patrice Horwath

Ralexar Investigational Site 21
Birmingham, AL United States
  Connect »

Patrice Horwath

Ralexar Investigational Site 18
Laguna Hills, CA United States
  Connect »

Patrice Horwath

Ralexar Investigational Site 23
Los Angeles, CA United States
  Connect »

Patrice Horwath

Ralexar Investigational Site 24
Oceanside, CA United States
  Connect »

Patrice Horwath

Ralexar Investigational Site 34
San Diego, CA United States
  Connect »

Patrice Horwath

Ralexar Investigational Site 16
San Diego, CA United States
  Connect »

Patrice Horwath

Ralexar Investigational Site 33
San Diego, CA United States
  Connect »

Patrice Horwath

Ralexar Investigational Site 27
Santa Monica, CA United States
  Connect »

Patrice Horwath

Ralexar Investigational Site 1
Miami, FL United States
  Connect »

Patrice Horwath

Ralexar Investigational Site 14
Pinellas Park, FL United States
  Connect »

Patrice Horwath

Ralexar Investigational Site 22
Tampa, FL United States
  Connect »

Patrice Horwath

Ralexar Investigational Site 29
Snellville, GA United States
  Connect »

Patrice Horwath

Ralexar Investigational Site 17
New Albany, IN United States
  Connect »

Patrice Horwath

Ralexar Investigational Site 32
Louisville, KY United States
  Connect »

Patrice Horwath

Ralexar Investigational Site 7
Louisville, KY United States
  Connect »

Patrice Horwath

Ralexar Investigational Site 11
Warren, MI United States
  Connect »

Patrice Horwath

Ralexar Investigational Site 15
Fridley, MN United States
  Connect »

Patrice Horwath

Ralexar Investigational Site 25
Saint Joseph, MO United States
  Connect »

Patrice Horwath

Ralexar Investigational Site 26
Albuquerque, NM United States
  Connect »

Patrice Horwath

Ralexar Investigational Site 20
New York, NY United States
  Connect »

Patrice Horwath

Ralexar Investigational Site 30
Stony Brook, NY United States
  Connect »

Patrice Horwath

Ralexar Investigational Site 28
Charlotte, NC United States
  Connect »

Patrice Horwath

Ralexar Investigational Site 12
Beachwood, OH United States
  Connect »

Patrice Horwath

Ralexar Investigational Site 5
Cincinnati, OH United States
  Connect »

Patrice Horwath

Ralexar Investigational Site 3
Oklahoma City, OK United States
  Connect »

Patrice Horwath

Ralexar Investigational Site 8
Johnston, RI United States
  Connect »

Patrice Horwath

Ralexar Investigational Site 6
Spartanburg, SC United States
  Connect »

Patrice Horwath

Ralexar Investigational Site 9
Nashville, TN United States
  Connect »

Patrice Horwath

Ralexar Investigational Site 19
Austin, TX United States
  Connect »

Patrice Horwath

Ralexar Investigational Site 31
Austin, TX United States
  Connect »

Patrice Horwath

Ralexar Investigational Site 4
Plano, TX United States
  Connect »

Patrice Horwath

Ralexar Investigational Site 2
San Antonio, TX United States
  Connect »

Patrice Horwath

Ralexar Investigational Site 13
Richmond, VA United States
  Connect »

Patrice Horwath

Ralexar Investigational Site 10
Spokane, WA United States
  Connect »